Skip to content
Chronic Pain Canada

Patient-Centred Innovations for Persons With Multimorbidity - Quebec

CompletedNot applicableNCT02789800
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

Brief summary (from the registry)

The aim of Patient-Centred Innovations for Persons With Multimorbidity (PACE in MM) study is to reorient the health care system from a single disease focus to a multimorbidity focus; centre on not only disease but also the patient in context; and realign the health care system from separate silos to coordinated collaborations in care. PACE in MM will propose multifaceted innovations in Chronic Disease Prevention and Management (CDPM) that will be grounded in current realities (i.e. Chronic Care Models including Self-Management Programs), that are linked to Primary Care (PC) reform efforts. The study will build on this firm foundation, will design and test promising innovations and will achieve transformation by creating structures to sustain relationships among researchers, decision-makers, practitioners, and patients. The Team will conduct inter-jurisdictional comparisons and is mainly a Quebec (QC) - Ontario (ON) collaboration with participation from 3 other provinces: British Columbia (BC); Manitoba (MB); and Nova Scotia (NS). The Team's objectives are: 1) to identify factors responsible for success or failure of current CDPM programs linked to the PC reform, by conducting a realist synthesis of their quantitative and qualitative evaluations; 2) to transform consenting CDPM programs identified in Objective 1, by aligning them to promising interventions on patient-centred care for multimorbidity patients, and to test these new innovations' in at least two jurisdictions and compare among jurisdictions; and 3) to foster the scaling-up of innovations informed by Objective 1 and tested/proven in Objective 2, and to conduct research on different approaches to scaling-up. This registration for Clinical Trials only pertains to Objective 2 of the study.

Study details

Official title
Patient-Centred Innovations for Persons With Multimorbidity - Quebec
Conditions
Interventions
  • Behavioral: DIMAC02
Sponsor
Université de Sherbrooke
Collaborators
Canadian Institutes of Health Research (CIHR); Western University, Canada; Agence de la Sante et des Services Sociaux du Saguenay-Lac-Saint-Jean
Start date
2016-04-22
Primary completion
2022-11-01
Sex
All
Age range
from 18 Years to 80 Years
Results posted
No results posted in this snapshot
Countries
Canada
Total sites listed
2

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
PATIENTS (Studies 2.1 \& 2.2): Inclusion Criteria: * 3+ Chronic Conditions * 18 to 80 years of age * Eligible for DIMAC02 intervention Exclusion Criteria: * Unable to reasonably respond to questionnaires or provide informed consent (ie. cognitive impairment or language barrier) * Deemed by provider to be too fragile CAREGIVERS (Study 2.1): * Close family member (wife/husband, parent, son/daughter, brother/sister) and/or caregiver to a patient that has received DIMAC02 intervention (first component) * Sharing time with the patient (before, during and after the intervention) * French speaking DECISION-MAKERS (Study 2.1): * FMG Physician-Manager, FMG Coordinators, Decision-Makers/Managers * Involved/Familiar with DIMAC02 program DIMAC02 INTERDISCIPLINARY team (Study 2.1): * Nurse, Nutritionist, Kinesiologist, Social Worker, Psychologist * Has delivered DIMAC02 intervention to at least one patient REFERRAL PROFESSIONALS (Study 2.1): \- Family physician or nurse/nurse practitioner

Canadian sites (2)

FacilityCityProvince
CIUSSS du Sageunay-Lac-Saint-JeanChicoutimiQuebec
Université de SherbrookeChicoutimiQuebec

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02789800